Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1171, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Amendments to the requirements for brandname-drug patents have been proposed by the US FDA
Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. :
The US FDA has approved acetadote [acetylcysteine] labelling updates
Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. :
The US Public Citizen group has requested that the FDA remove leflunomide [`Arava']
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
The US FDA has issued a statement on the use of conjugated estrogens/medroxyprogesterone
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :